EMERGENT BIOSOLUTIONS INC. Shares Outstanding (Cover Page)
EMERGENT BIOSOLUTIONS INC. (EBS) had Shares Outstanding (Cover Page) of 51.27 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 51.27M shares.
- 2026-04-23: Entity Common Stock, Shares Outstanding 51.60M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 51.77M shares.
- 2025-10-22: Entity Common Stock, Shares Outstanding 52.52M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 51.27M shares 10-Q · filed 2026-08-06 |
| 2026-04-23 | 51.60M shares 10-Q · filed 2026-05-01 |
| 2026-02-19 | 51.77M shares 10-K · filed 2026-02-27 |
| 2025-10-22 | 52.52M shares 10-Q · filed 2025-10-30 |
| 2025-07-30 | 53.35M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 54.28M shares 10-Q · filed 2025-05-08 |
| 2025-02-25 | 54.34M shares 10-K · filed 2025-03-04 |
| 2024-10-30 | 54.18M shares 10-Q · filed 2024-11-07 |
| 2024-07-30 | 52.91M shares 10-Q · filed 2024-08-07 |
| 2024-04-25 | 52.40M shares 10-Q · filed 2024-05-02 |
| 2024-02-28 | 52.20M shares 10-K · filed 2024-03-08 |
| 2023-12-01 | 51.88M shares 10-Q · filed 2023-12-11 |
| 2023-08-01 | 51.81M shares 10-Q · filed 2023-08-09 |
| 2023-05-02 | 50.45M shares 10-Q · filed 2023-05-10 |
| 2023-02-22 | 50.14M shares 10-K/A · filed 2023-12-11 |
| 2022-11-01 | 49.89M shares 10-Q · filed 2022-11-09 |
| 2022-07-26 | 49.86M shares 10-Q · filed 2022-08-02 |
| 2022-04-22 | 50.24M shares 10-Q · filed 2022-04-29 |
| 2022-02-18 | 50.50M shares 10-K · filed 2022-02-25 |
| 2021-10-29 | 53.80M shares 10-Q · filed 2021-11-05 |
| 2021-07-23 | 53.70M shares 10-Q · filed 2021-07-30 |
| 2021-04-23 | 53.59M shares 10-Q · filed 2021-04-30 |
| 2021-02-12 | 53.30M shares 10-K · filed 2021-02-19 |
| 2020-10-30 | 53.00M shares 10-Q · filed 2020-11-06 |
| 2020-07-24 | 52.92M shares 10-Q · filed 2020-07-31 |
| 2020-04-24 | 52.43M shares 10-Q · filed 2020-05-01 |
| 2020-02-14 | 52.00M shares 10-K · filed 2020-02-25 |
| 2019-10-30 | 51.62M shares 10-Q · filed 2019-11-07 |
| 2019-07-26 | 51.60M shares 10-Q · filed 2019-08-02 |
| 2019-04-26 | 51.40M shares 10-Q · filed 2019-05-08 |
| 2019-02-15 | 51.20M shares 10-K · filed 2019-02-22 |
| 2018-10-26 | 50.95M shares 10-Q · filed 2018-11-02 |
| 2018-07-27 | 50.02M shares 10-Q · filed 2018-08-03 |
| 2018-04-27 | 49.82M shares 10-Q · filed 2018-05-04 |
| 2018-02-16 | 49.49M shares 10-K · filed 2018-02-23 |
| 2017-09-30 | 41.40M shares 10-Q · filed 2017-11-03 |
| 2017-07-28 | 41.21M shares 10-Q · filed 2017-08-04 |
| 2017-04-28 | 40.97M shares 10-Q · filed 2017-05-05 |
| 2017-02-17 | 40.69M shares 10-K · filed 2017-02-28 |
| 2016-10-31 | 40.50M shares 10-Q · filed 2016-11-09 |
| 2016-07-29 | 40.46M shares 10-Q · filed 2016-08-05 |
| 2016-04-29 | 40.06M shares 10-Q · filed 2016-05-06 |
| 2016-02-19 | 0.00 shares 10-K · filed 2016-02-29 |
| 2015-10-30 | 38.94M shares 10-Q · filed 2015-11-06 |
| 2015-07-31 | 38.80M shares 10-Q · filed 2015-08-06 |
| 2015-04-30 | 38.36M shares 10-Q · filed 2015-05-08 |
| 2015-02-27 | 37.92M shares 10-K · filed 2015-03-09 |
| 2014-10-31 | 37.55M shares 10-Q · filed 2014-11-10 |
| 2014-07-31 | 37.48M shares 10-Q · filed 2014-08-08 |
| 2014-04-30 | 37.41M shares 10-Q · filed 2014-05-12 |
| 2014-02-28 | 36.77M shares 10-K · filed 2014-03-10 |
| 2013-10-31 | 36.37M shares 10-Q · filed 2013-11-08 |
| 2013-06-30 | 36.27M shares 10-Q · filed 2013-08-06 |
| 2013-03-31 | 36.12M shares 10-Q · filed 2013-05-03 |
| 2013-02-28 | 35.93M shares 10-K · filed 2013-03-08 |
| 2012-10-26 | 35.85M shares 10-Q · filed 2012-11-01 |
| 2012-07-31 | 36.20M shares 10-Q · filed 2012-08-03 |
| 2012-03-31 | 36.16M shares 10-Q · filed 2012-05-04 |
| 2012-02-29 | 36.01M shares 10-K · filed 2012-03-09 |
| 2011-09-30 | 35.95M shares 10-Q · filed 2011-11-04 |
| 2011-06-30 | 35.85M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |